Xero Add to your watchlist.
1H26: Overall, a weaker result vs market expectations despite EBITDA a slight beat. EBITDA-capex cash flow came in -6% below consensus. Whilst operating costs have seen good control, capex spend is trending up due to investments in new AI capabilities.
You're not a member! Trial today
Look for buying interest to rebuild, and we’ll revisit the entry point once the price action is above the 10-day average.
